ALVAREZ CESAR L 4

What Happened
Cesar L. Alvarez, a director of Precigen, had 71,839 restricted stock units (RSUs) vest on March 13, 2026 and those RSUs were converted into 71,839 shares of Precigen common stock. The Form 4 shows an acquisition via conversion (derivative exercise/conversion) for 71,839 shares and a simultaneous disposition of 71,839 derivative units at $0.00; no purchase price or cash payment is reported for the shares.

Key Details

• Transaction date: March 13, 2026. Filing date (Form 4): March 16, 2026. No late-filing flag is indicated in the provided data.
• Reported transactions: (1) 71,839 shares acquired by exercise/conversion of derivative (M); (2) 71,839 shares disposed (derivative) at $0.00.
• Price / value: $0.00 reported on the disposition line; acquisition is conversion of RSUs (no cash paid).
• Shares owned after transaction: Not provided in the supplied filing data.
• Footnotes: F1 — each RSU represents a contingent right to one share; F2 — the RSUs vested in full on March 13, 2026.

Context
This was a conversion/settlement of RSUs upon vesting, not an open‑market purchase or sale. Filings for RSU vesting often show both an acquisition (conversion of the derivative right into shares) and a technical disposition line (often $0.00) reflecting the derivative-to-stock settlement; such entries do not necessarily indicate a market sale or a cash transaction.